Submission of Matter to a Vote of Security Holders

On June 9, 2021, Fuse Medical, Inc. (the 'Company') held its 2021 Annual Meeting of Stockholders (the 'Annual Meeting'). The total number of shares of common stock eligible to vote as of the record date, April 14, 2021, was 73,124,458 and, pursuant to the Company's Bylaws, 36,562,230 shares were required to be present or represented at the Annual Meeting to constitute a quorum. The total number of shares of common stock present or represented at the Annual Meeting was 66,190,678, and a quorum therefore existed.

At the Annual Meeting:

1.

Election of Board of Directors. The following persons were elected as directors of the Company for a one-year term expiring at the 2022 Annual Meeting of Stockholders with the following vote:


Name


Votes For


Votes Against


Votes Withheld

Broker
Non-Votes

Renato V. Bosita, Jr., MD

64,700,611

0

72,230

1,417,837

Mark W. Brooks

64,700,642

0

72,199

1,417,837

William E. McLaughlin, III

64,698,148

0

74,693

1,417,837

Christopher C. Reeg

64,700,648

0

72,193

1,417,837

2.

Ratification of the Selection of Armanino LLP ('Armanino'). The selection of Armanino to act as independent registered public accounting firm for the Company for the fiscal year ending December 31, 2021 was ratified by a vote of (i) 66,147,916 in favor, (ii) 42,762 against, and (iii) zero abstaining.

1

Attachments

  • Original document
  • Permalink

Disclaimer

Fuse Medical Inc. published this content on 10 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 June 2021 10:07:14 UTC.